ANTAZOLINE PHOSPHATE
UNII VPR5FPH326

Substance Identification & Data

This profile provides standardized clinical and technical data for Antazoline Phosphate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VPR5FPH326.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 154-68-7 and the RxNorm Concept ID (RxCUI) 866. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VPR5FPH326

CAS Registry Number

154-68-7

RxNorm Concept ID

866

Detailed Substance Profile

Preferred Name

ANTAZOLINE PHOSPHATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C17H19N3.H3O4P

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DUIGUKRYYAGJAF-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C47399

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

158798

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1ccc(cc1)CN(CC2=NCCN2)c3ccccc3.OP(=O)(O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Antazoline Phosphate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.